RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aurinia Pharmaceuticals appoints CEO

AuriniaAurinia Pharmaceuticals, a clinical stage biopharmaceutical company, appointed Richard M. Glickman, the company's founder and chairman of the board, as chairman and chief executive officer.
Article continues below

READ MORE Aurinia Pharma appoints Charles Rowland as CEO

Dr. Glickman brings over 30 years of experience in the creation and operation of healthcare ventures, founding and co-founding numerous companies during his career.

Dr. Glickman currently serves as founding Chairman of Essa Pharmaceuticals Inc., Chairman of the Board of Engene Corporation and a Director of Cardiome Pharma. He is also a Partner at Lumira Capital, one of Canada’s most successful healthcare focused venture capital firms.

Dr. Glickman has served on numerous biotechnology and community boards, including member of the federal government’s National Biotechnology Advisory Committee, Director of the Canadian Genetic Disease Network, Chairman of Life Sciences B.C. and a member of the British Columbia Innovation Council.

Dr. Glickman is the recipient of numerous awards including the Ernst and Young Entrepreneur of the Year, a recipient of both BC and Canada’s Top 40 under 40 award, the BC Lifesciences Leadership Award and the Corporate Leadership Award from the Lupus Foundation of America (LFA).

 LATEST MOVES FROM British Columbia 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy